(19) |
 |
|
(11) |
EP 0 294 025 A3 |
(12) |
EUROPEAN PATENT APPLICATION |
(88) |
Date of publication A3: |
|
08.11.1989 Bulletin 1989/45 |
(43) |
Date of publication A2: |
|
07.12.1988 Bulletin 1988/49 |
(22) |
Date of filing: 27.04.1988 |
|
|
(84) |
Designated Contracting States: |
|
AT BE CH DE ES FR GB GR IT LI LU NL SE |
(30) |
Priority: |
01.05.1987 US 45032
|
(71) |
Applicant: THE SCRIPPS RESEARCH INSTITUTE |
|
La Jolla, CA 92037 (US) |
|
(72) |
Inventors: |
|
- Zimmerman, Theodore S.
La Jolla
California 92037 (US)
- Fulcher, Carol A.
La Jolla
California 92037 (US)
- Foster, Paul A.
San Diego
California 92126 (US)
|
(74) |
Representative: Jump, Timothy John Simon et al |
|
Venner Shipley & Co.
20 Little Britain London EC1A 7DH London EC1A 7DH (GB) |
|
|
|
|
|
Remarks: |
|
The title of the invention has been amended (Guidelines for Examination in the EPO,
A-III, 7.3). |
|
(54) |
Peptides corresponding to the Factor VIII binding domain of the von Willebrand factor |
(57) Peptides which inhibit the binding of von Willebrand Factor to Factor VIII. Monoclonal
antibodies capable of specifically binding to the region of von Willebrand Factor
containing the Factor VIII binding domain. Improved methods of preparing Factor VIII.